Marc Tischkowitz

34.6k total citations · 4 hit papers
157 papers, 7.3k citations indexed

About

Marc Tischkowitz is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Marc Tischkowitz has authored 157 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Genetics, 72 papers in Molecular Biology and 45 papers in Cancer Research. Recurrent topics in Marc Tischkowitz's work include BRCA gene mutations in cancer (78 papers), DNA Repair Mechanisms (45 papers) and Cancer Genomics and Diagnostics (30 papers). Marc Tischkowitz is often cited by papers focused on BRCA gene mutations in cancer (78 papers), DNA Repair Mechanisms (45 papers) and Cancer Genomics and Diagnostics (30 papers). Marc Tischkowitz collaborates with scholars based in United Kingdom, Canada and United States. Marc Tischkowitz's co-authors include William D. Foulkes, David G. Huntsman, Antonis C. Antoniou, Christopher G. Mathew, Douglas F. Easton, Bing Xia, Philippe M. Campeau, Katherine Schon, Paul D.P. Pharoah and André Robidoux and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Marc Tischkowitz

149 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

2011 850 citations Marc Tischkowitz, David G. Huntsman et al. profile →
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

2015 579 citations Douglas F. Easton, Paul D.P. Pharoah et al. profile →
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

2019 386 citations Andrew Lee, Alex Cunningham et al. Genetics in Medicine profile →
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

2024 67 citations Marc Tischkowitz, Mark E. Robson et al. profile →

Peers

Countries citing papers authored by Marc Tischkowitz

Since Specialization

Citations

This map shows the geographic impact of Marc Tischkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Tischkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Tischkowitz more than expected).

Fields of papers citing papers by Marc Tischkowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Tischkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Tischkowitz. The network helps show where Marc Tischkowitz may publish in the future.

Co-authorship network of co-authors of Marc Tischkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Tischkowitz. A scholar is included among the top collaborators of Marc Tischkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Tischkowitz. Marc Tischkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer 2025 ·PubMed ·(unknown), (unknown), (unknown), Craig Knott, (unknown), Catherine Huntley, (unknown), Yvonne Walburga Joko-Fru, Eva Morris, Steven Hardy, Bethany Torr, Diana Eccles, Clare Turnbull, Marc Tischkowitz, Paul D.P. Pharoah, Antonis C Antoniou	1
2	Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group 2025 ·Clinical Cancer Research ·Andrew Dhawan, (unknown), (unknown), Lamis Yehia, (unknown), (unknown), Marc Tischkowitz, Suzanne P. MacFarland, Joanne Ngeow, Nicoline Hoogerbrugge, Charis Eng	1
3	Patterns of referrals to regional clinical genetics services for women potentially at above-population level risk of breast cancer 2024 ·PubMed ·Juliet A. Usher‐Smith, (unknown), (unknown), Abdul Badran, (unknown), Andrea Forman, Katie Snape, Antonis C. Antoniou, Marc Tischkowitz	1
4	Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling study 2024 ·British Journal of General Practice ·Catherine Huntley, Bethany Torr, (unknown), Angela George, Helen Hanson, Katie Snape, John Broggio, L. A. Glasgow, Marc Tischkowitz, D. Gareth Evans, Antonis C. Antoniou, Clare Turnbull	1
5	Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing 2024 ·Annals of Oncology ·Charlie F Rowlands, (unknown), Judith Balmañà, Susan M. Domchek, D. Gareth Evans, Helen Hanson, Nicoline Hoogerbrugge, Philip James, (unknown), Mark E. Robson, Marc Tischkowitz, William D. Foulkes, Clare Turnbull	7
6	Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK Biobank 2024 ·British Journal of Cancer ·Xin Yang, Yujia Wu, (unknown), (unknown), Joe Dennis, Jonathan P. Tyrer, Tim Carver, (unknown), Marc Tischkowitz, Paul D.P. Pharoah, Douglas F. Easton, Antonis C. Antoniou	3
7	Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) 2024 ·Genetics in Medicine ·Tuya Pal, Katherine Schon, (unknown), Judith Balmañà, William D. Foulkes, Paul A. James, Susan Klugman, Alicia A. Livinski, Julie Mak, Joanne Ngeow, Nicoleta Voian, Myra Wick, Helen Hanson, Douglas R. Stewart, Marc Tischkowitz	6
8	Exploring the barriers to and facilitators of implementing CanRisk in primary care: a qualitative thematic framework analysis 2023 ·British Journal of General Practice ·Stephanie Archer, (unknown), Tim Carver, (unknown), Alex Cunningham, (unknown), Marc Tischkowitz, Douglas F. Easton, Antonis C. Antoniou, Jon Emery, Juliet A. Usher‐Smith, Fiona M Walter	7
9	Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis 2022 ·British Journal of Cancer ·(unknown), (unknown), Eleni Sofianopoulou, Diana Eccles, Clare Turnbull, Marc Tischkowitz, Paul D.P. Pharoah, Antonis C. Antoniou	9
10	Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations 2020 ·Journal of Medical Genetics ·Alice Garrett, Miranda Durkie, Alison Callaway, George J. Burghel, Rachel Robinson, James Drummond, Bethany Torr, Cankut Çubuk, Ian Berry, Andrew J. Wallace, Sian Ellard, Diana Eccles, Marc Tischkowitz, Helen Hanson, Clare Turnbull	36
11	Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines 2020 ·Clinical Cancer Research ·Marc Tischkowitz, Sidong Huang, Susana Banerjee, Jennifer Hague, William P.D. Hendricks, David G. Huntsman, Jessica D. Lang, Krystal A. Orlando, Amit M. Oza, Patricia Pautier, Isabelle Ray‐Coquard, Jeffrey M. Trent, Michael Witcher, Leora Witkowski, W. Glenn McCluggage, Douglas A. Levine, William D. Foulkes, Bernard E. Weissman	84
12	The clinical presentation caused by truncating CHD8 variants 2019 ·Clinical Genetics ·Sofia Douzgou, Hui Liang, Kay Metcalfe, (unknown), Marc Tischkowitz, (unknown), Usha Kini, Shane McKee, Laura Yates, Marta Bertoli, Sally Ann Lynch, Susan Holder, (unknown), (unknown)	26
13	Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP 2019 ·Nature Communications ·Anja Thormann, Mihail Halachev, William McLaren, David Moore, Victoria Svinti, Archie Campbell, Shona M. Kerr, Marc Tischkowitz, Sarah Hunt, Malcolm G. Dunlop, Matthew E. Hurles, Caroline F. Wright, Helen V. Firth, Fiona Cunningham, David Fitzpatrick	53
14	Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab 2018 ·Seminars in Oncology ·Ruth Casey, Olivier Giger, Ian Seetho, Alison Marker, (unknown), Louise H. Boyle, Mark Gurnell, Ashley Shaw, Marc Tischkowitz, Eamonn R. Maher, Krishna Chatterjee, Tobias Janowitz, George Mells, Pippa Corrie, Benjamin Challis	23
15	Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group 2018 ·Journal of Medical Genetics ·Amy Taylor, Angela F. Brady, Ian M. Frayling, Helen Hanson, Marc Tischkowitz, Clare Turnbull, Lucy Side	68
16	Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access 2017 ·Journal of Genetic Counseling ·(unknown), Samantha Flynn, (unknown), James D. Brenton, Robin Crawford, Marc Tischkowitz, Nick Hulbert-Williams, (unknown)	14
17	Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model 2016 ·Genetics in Medicine ·Andrew Lee, Alex Cunningham, Marc Tischkowitz, Jacques Simard, Paul D.P. Pharoah, Douglas F. Easton, Antonis C. Antoniou	58
18	Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer 2012 ·Cancer Discovery ·Susan M. Domchek, Jiang-bo Tang, Jill E. Stopfer, Dana R. Lilli, Nancy Hamel, Marc Tischkowitz, Álvaro N.A. Monteiro, Troy E. Messick, Jacquelyn M. Powers, (unknown), Fergus J. Couch, David E. Goldgar, H. Rosemarie Davidson, Katherine L. Nathanson, William D. Foulkes, Roger A. Greenberg	101
19	The Basal Phenotype of BRCA1-Related Breast Cancer: Past, Present and Future 2006 ·Cell Cycle ·Marc Tischkowitz, William D. Foulkes	39
20	Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia 2003 ·European Journal of Human Genetics ·Marc Tischkowitz, Najim Ameziane, Quinten Waisfisz, Peter de Winter, R. J. C. Harris, Reinhard Stöger, Shirley Hodgson, Christopher G. Mathew, Hans Joenje	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact